Talking Precision Medicine

Genialis
  • 5.0（1則評分）
  • 生命科學
  • 每月更新

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.

  1. 5月20日

    Kamal Jethwani | The concierge CEO: Incubating the next generation of digital oncology companies | TPM podcast #56

    In this episode, Rafael Rosengarten sits down with Dr. Kamal Jethwani, VP of Digital Ventures at Moffitt Cancer Center, CEO of AccelerOnc Studio, and consulting CEO of Decimal Health. With over two decades in digital health, Kamal shares how Moffitt is transforming cutting-edge oncology expertise into scalable AI-native companies, why operational implementation matters more than most founders realize, and how digital health adoption succeeds or fails inside real clinical workflows. From “concierge MVPs” to explainable AI, the conversation covers the hard-won lessons of building digital health programs at the ground level and why oncology innovation may be entering a completely new era. ⁠⁠⁠⁠⁠TPM E565 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episode 56 links: Moffitt Cancer CenterAccelerOnc StudioDecimal Health

    38 分鐘

  2. 4月9日

    Shakti Ramkissoon | The Pulse of the Oncologist: Meeting clinicians and patients where they are to deliver precision medicine | TPM podcast #55

    Precision oncology promises more data, more insight, and better decisions, yet in practice it often brings more complexity. In a new episode Rafael Rosengarten is joined by Dr. Shakti Ramkissoon, VP of Oncology at Labcorp, to unpack the realities on the ground. From access gaps, reimbursement challenges and fragmented workflows to the promise of longitudinal data and AI-enabled clarity, Dr. Ramkissoon shares how Labcorp is working to simplify complexity while preserving what matters most: human connection in care. ⁠⁠⁠⁠TPM E55 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episode 55 links: Pulse of the Oncologist 2026 reportShakti Ramkissoon on LinkedIn

    48 分鐘

  3. 3月23日

    Sean Khozin | The rhythm and dissonance of cancer biology | TPM podcast #54

    In this episode, Rafael Rosengarten speaks with Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer. Sean shares how pre-competitive collaboration across industry, academia, and regulators is helping address some of the biggest challenges in oncology. The conversation explores the role of data sharing initiatives like Project Data Sphere, the promise of AI in clinical trials and discovery, and Sean’s unique journey from music to science. ⁠⁠⁠⁠TPM E54 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episode 54 links: CEO Roundtable on CancerProject Data SphereSean Khozin webpagePhyusionBio substackSean Khozin on LinkedIn

    45 分鐘

  4. 2月26日

    Colette Delawalla | Be the change you want to see in the world: mobilizing to protect American science | TPM podcast #53

    In this episode, I’m joined by Colette Delawalla, founder and CEO of Stand Up For Science. What began as frustration over a federal “banned words” list evolved into a national mobilization effort to defend scientific freedom and evidence-based policymaking. We talk about the organization’s origin story, its National Day of Action on March 7, 2026, the communication gap in science on the political left, the campaign to impeach RFK Jr., and what rebuilding American science might require in the years ahead. Come on in and have a listen. ⁠⁠⁠TPM E53 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episode 53 links: Stand Up For Science homepage National Day of Action map (March 7, 2026)Impeach RFK Jr. & the Quack-o-gram campaignArticles of impeachment against RFK Jr.Stand Up For Science SubredditBook recommendation: Nothing is True and Everything is Possible

    41 分鐘

  5. 2025/12/12

    Ian Simon | When following the science isn’t enough: risk, communication, and the future of biotechnology | TPM podcast #52

    In this episode, I’m joined by my longtime friend Ian Simon, Head of Biotechnology at Aspis Intelligence. Ian’s path runs from grad school vaccine research at Yale to senior roles at the White House, HHS, NIH, the State Department, and the Office of Long Covid. We talk about de-risking young biotech companies, what Covid taught us about science and public health, and how new technologies like AI might change how we do science altogether.  ⁠⁠⁠TPM E52 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episode 52 links: Ian Simon on LinkedInAspis Intelligence

    40 分鐘

  6. 2025/11/13

    Michelle Chen | Using AI to derisk gene therapy and genetic medicine | TPM podcast #51

    In this episode Rafael sits down with Michelle Chen, President and CEO of Form Bio, a techbio company using AI to advance genome engineering and the development of genetic medicines. Michelle shares her zigzag journey from scientist to executive, how her team is tackling the biggest bottlenecks in gene therapy, and why AI has become essential in designing safer, more effective treatments. ⁠⁠TPM E51 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episode 51 links: Michelle Chen on LinkedInForm Bio

    36 分鐘

  7. 2025/10/30

    Mike Rossi, ConcertAI | Real world data and artificial intelligence turn anecdote to evidence | TPM podcast #50

    Today I’m joined by Mike Rossi, Vice President of Translational Science and Multi-modal Real-World Evidence Solutions at ConcertAI. Mike has built a career at the intersection of genomics, data science, and oncology, helping to bridge the gap between research and real-world clinical practice. We talk about what real-world data really means, how it becomes actionable evidence, and what it takes to turn the messy reality of patient care into insight that changes lives. ⁠⁠TPM E50 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episode 50 links: Mike Rossi on LinkedInConcertAI

    45 分鐘

  8. 2025/08/29

    Mida Pezeshkian, Stema_cg | Launching products in healthcare: The most important framework is flexibility | TPM podcast #49

    Joining us on this episode is Mida Pezeshkian, an old colleague and friend. Mida’s career has spanned from the depths of stem cell science as a student to her current focus on product management in healthcare. We talk about what it really takes to launch products in this space, and how she helps customers bring truly transformational innovations to market. ⁠⁠TPM E49 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episode 49 links: Mida Pezeshkian on LinkedInSTEMA_cgThe Lab

    45 分鐘
顯示全部 (56)

簡介

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.

資訊

  • 創作者
    Genialis
  • 活躍年代
    2019年 - 2026年
  • 集數
    56
  • 年齡分級
    兒少適宜
  • 版權
    © 908529
  • 節目網站
    Talking Precision Medicine

你可能也會喜歡